These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 240046)

  • 21. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
    Reffo GC; Pitzorno G; Perin S; Forattini C
    Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta-blockers in the treatment of hypertension in elderly patients].
    Lefflerová K; Widimský J; Lupínek Z
    Vnitr Lek; 1991 Feb; 37(2):128-34. PubMed ID: 1673577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study with Tobanum and Visken in hypertensive patients.
    Torma Z; Grubic V; Unyi G
    Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
    [No Abstract]   [Full Text] [Related]  

  • 24. [Beta-blockaders in the treatment of hypertension in pregnancy].
    Kawecka-Jaszcz K; Skoczeń M
    Kardiol Pol; 1985; 28(5):334-9. PubMed ID: 2864465
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-arrhythmic effects of LB-46 on experimentally produced digitoxic arrhythmias.
    Gupta MC; Mathur KS; Dalal S
    Indian Heart J; 1972 Jun; 24():Suppl 1:224-5. PubMed ID: 4147276
    [No Abstract]   [Full Text] [Related]  

  • 28. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
    Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
    Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical application of beta-blockaders].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive effect of a long-acting beta blockader].
    Schultze G; Dissmann T; Oelkers W
    Verh Dtsch Ges Inn Med; 1975; 81():1642-4. PubMed ID: 5833
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
    Mattioli G; Ricci S; Menozzi A; Teglio V
    Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Comparison of antihypertensive effectiveness of beta-adrenoceptor antagonists with different pharmacological properties.
    Taylor SH; Davidson C; Singleton W; Thadani U
    Br Heart J; 1976 Mar; 38(3):313. PubMed ID: 4081
    [No Abstract]   [Full Text] [Related]  

  • 35. [What is assured in treatment with beta receptor blockaders?].
    von Egidy H
    Internist (Berl); 1972 Dec; 13(12):481-4. PubMed ID: 4405768
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T; Aquaro G
    Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effects of LB-46 (Carvisken) on tachycardia in hyperthyroidism].
    Makiuchi M
    Horumon To Rinsho; 1973 Dec; 21(12):1265-9. PubMed ID: 4130956
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide].
    Heinze A; Wessels F
    Verh Dtsch Ges Inn Med; 1974; 80():272-4. PubMed ID: 4156115
    [No Abstract]   [Full Text] [Related]  

  • 39. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(9):91-6. PubMed ID: 1684678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.